These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32731576)

  • 41. Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Ligands.
    Harland AA; Bender AM; Griggs NW; Gao C; Anand JP; Pogozheva ID; Traynor JR; Jutkiewicz EM; Mosberg HI
    J Med Chem; 2016 May; 59(10):4985-98. PubMed ID: 27148755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment with a heme oxygenase 1 inducer enhances the antinociceptive effects of µ-opioid, δ-opioid, and cannabinoid 2 receptors during inflammatory pain.
    Carcolé M; Castany S; Leánez S; Pol O
    J Pharmacol Exp Ther; 2014 Oct; 351(1):224-32. PubMed ID: 25204546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors.
    Agnes RS; Lee YS; Davis P; Ma SW; Badghisi H; Porreca F; Lai J; Hruby VJ
    J Med Chem; 2006 May; 49(10):2868-75. PubMed ID: 16686530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spinal antinociceptive effects of AA501, a novel chimeric peptide with opioid receptor agonist and tachykinin receptor antagonist moieties.
    Bonney IM; Foran SE; Marchand JE; Lipkowski AW; Carr DB
    Eur J Pharmacol; 2004 Mar; 488(1-3):91-9. PubMed ID: 15044040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.
    Chen SL; Ma HI; Han JM; Lu RB; Tao PL; Law PY; Loh HH
    J Biomed Sci; 2010 Apr; 17(1):28. PubMed ID: 20403204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors.
    Sinha B; Cao Z; Murray TF; Aldrich JV
    J Med Chem; 2009 Dec; 52(23):7372-5. PubMed ID: 19621878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of Dmt-D-Lys-Phe-Phe-OH as a highly antinociceptive tetrapeptide metabolite of the opioid-neurotensin hybrid peptide PK20.
    Kleczkowska P; Bojnik E; Leśniak A; Kosson P; Van den Eynde I; Ballet S; Benyhe S; Tourwé D; Lipkowski AW
    Pharmacol Rep; 2013; 65(4):836-46. PubMed ID: 24145077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands.
    Bender AM; Clark MJ; Agius MP; Traynor JR; Mosberg HI
    Bioorg Med Chem Lett; 2014 Jan; 24(2):548-51. PubMed ID: 24365161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of Carfentanil Amide Opioids Using the Ugi Multicomponent Reaction.
    Váradi A; Palmer TC; Haselton N; Afonin D; Subrath JJ; Le Rouzic V; Hunkele A; Pasternak GW; Marrone GF; Borics A; Majumdar S
    ACS Chem Neurosci; 2015 Sep; 6(9):1570-7. PubMed ID: 26148793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.
    Perlikowska R; Piekielna J; Gentilucci L; De Marco R; Cerlesi MC; Calo G; Artali R; Tömböly C; Kluczyk A; Janecka A
    Eur J Med Chem; 2016 Feb; 109():276-86. PubMed ID: 26785295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy.
    Lacko E; Varadi A; Rapavi R; Zador F; Riba P; Benyhe S; Borsodi A; Hosztafi S; Timar J; Noszal B; Furst S; Al-Khrasani M
    Curr Med Chem; 2012; 19(27):4699-707. PubMed ID: 22934777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of 3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)-N-phenylpiperidine-1-carboxamide as novel potent analgesic.
    Huang H; Wang W; Xu X; Zhu C; Wang Y; Liu J; Li W; Fu W
    Eur J Med Chem; 2020 Mar; 189():112070. PubMed ID: 31982651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 'Carba'-carfentanil (trans isomer): a μ opioid receptor (MOR) partial agonist with a distinct binding mode.
    Weltrowska G; Lemieux C; Chung NN; Guo JJ; Wilkes BC; Schiller PW
    Bioorg Med Chem; 2014 Sep; 22(17):4581-6. PubMed ID: 25129170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
    Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
    Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and Antinociceptive Effect of Some Thiazole-Piperazine Derivatives: Involvement of Opioidergic System in the Activity.
    Yücel NT; Osmaniye D; Kandemir Ü; Evren AE; Can ÖD; Demir Özkay Ü
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34199486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, biological evaluation, and automated docking of constrained analogues of the opioid peptide H-Dmt-D-Ala-Phe-Gly-NH₂ using the 4- or 5-methyl substituted 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one scaffold.
    De Wachter R; de Graaf C; Keresztes A; Vandormael B; Ballet S; Tóth G; Rognan D; Tourwé D
    J Med Chem; 2011 Oct; 54(19):6538-47. PubMed ID: 21870874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Major effect of pyrrolic N-benzylation in norbinaltorphimine, the selective kappa-opioid receptor antagonist.
    Chauvignac C; Miller CN; Srivastava SK; Lewis JW; Husbands SM; Traynor JR
    J Med Chem; 2005 Mar; 48(5):1676-9. PubMed ID: 15743210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.
    Bonner GG; Davis P; Stropova D; Edsall S; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 2000 Feb; 43(4):569-80. PubMed ID: 10691683
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities.
    Nair P; Yamamoto T; Largent-Milnes TM; Cowell S; Kulkarni V; Moye S; Navratilova E; Davis P; Ma SW; Vanderah TW; Lai J; Porreca F; Hruby VJ
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4975-8. PubMed ID: 23899615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.